Recurrence-free survival | Overall survival | |||||
---|---|---|---|---|---|---|
HR | 95% CI | P | HR | 95% CI | P | |
Age | 0.99 | 0.95–1.03 | 0.573 | 1.00 | 0.96–1.04 | 0.980 |
BMI | 0.99 | 0.88–1.12 | 0.892 | 0.97 | 0.85–1.11 | 0.684 |
Stage | 1.51 | 1.03–2.21 | 0.034* | 1.40 | 0.90-2.17 | 0.136 |
Preoperative | ||||||
Alb | 0.99 | 0.86–1.13 | 0.866 | 0.99 | 0.83–1.18 | 0.906 |
Glb | 1.09 | 0.99–1.19 | 0.055 | 1.08 | 0.99–1.19 | 0.094 |
Hgb | 1.01 | 0.98–1.05 | 0.420 | 1.00 | 0.96–1.05 | 0.816 |
Post-operative | ||||||
Alb < 32 g/L | 3.60 | 1.05–12.42 | 0.042* | 9.95 | 1.81-54.80 | 0.008* |
Hgb | 1.00 | 0.97-1.04 | 0.966 | 1.02 | 0.98–1.06 | 0.418 |